A comprehensive view of Oral Medicines/Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Rise Therapeutics Announces FDA Clearance of its IND Application to Initiate a Phase 1 Study of an Oral Immunotherapy for the Treatment of Ulcerative Colitis

Health Canada approves Apex Labs’ take home psilocybin clinical trial; study to evaluate efficacy, safety, tolerability of APEX-52, a microdose, oral synthetic psilocybin drug product to treat depression, anxiety in adults diagnosed with PTSD

Dr. Reddy's acquires trademark rights from Pfizer for Primcyv breast cancer drug as an oral capsule in India; Dr. Reddy's to manufacture Primcyv’s active pharmaceutical ingredient and finished drug at its FDA-approved state-of-the-art facilities

Novo Nordisk announces FDA approval of label update for Rybelsus allowing use as a first-line option for adults with type 2 diabetes

Bristol-Myers Squibb Listed a New Clinical Trial to Study of Absorption, Metabolism, and Elimination of oral CC-90010 in Participants With Advanced Solid Tumors

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count